AZN AstraZeneca Plc

47.440.07 (+0.15%)
Close: November 15, 2019

Quote

Previous Close
$47.44
Day Range
$46.81-$47.53
52 Week Range
$35.30-$49.21
Volume
2,275,928
Avg Volume
3,103,201
Dividend TTM
$1.37 (2.89%)
Ex-Dividend Date
2019-08-08

Valuation

Market Cap
$124.47B
Enterprise Value (EV)
$137.72B
PE Ratio
59.03
EV/EBITDA
29.89
Price/Sales
5.64
Price/Book
9.97
PEG Ratio
1.49

Financials

Revenue
$22.05B
Gross Profit
$15.83B
EBITDA
$4.61B
EPS, ttm
$0.80
Profit Margin
9.76%
Revenue/Employee
$342.43K
Next Earnings Date
2/14/2020 (91 days)
Debt to Equity
153%
Debt
$18.93B
Cash
$5.68B
Net Debt
$13.25B

Performance

Beta
0.41
200 Day Moving Avg
$41.90
50 Day Moving Avg
$45.09
52 Week Change
14.42%
YTD Change
25.47%
1 Month Change
7.15%
3 Month Change
7.22%
6 Month Change
25.72%
1 Year Change
14.42%
2 Year Change
42.47%
5 Year Change
30.07%

Share Count

Shares Outstanding
2.6B
Float
2.6B
Restricted Shares
7.9K
Restricted Shares, %
0.00%

AstraZeneca Plc Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Pascal Soriot

Website: http://astrazeneca.com

Description: AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Employees: 64,400